Dr. Powers is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 21st Ave S
Nashville, TN 37232Phone+1 615-936-7678Fax+1 615-936-0063
Summary
- Dr. Alvin Powers, an endocrinologist in Nashville, TN, is affiliated with Vanderbilt University Medical Center and Tennessee Valley Healthcare System. He received his medical degree from the University of Tennessee Health Science Center College of Medicine, completed a residency in internal medicine at Duke and an endocrinology fellowship at the Massachusetts General Hospital. He has been in practice for 35 years. He specializes in diabetes and endocrinology. He is an experienced endocrinologist (adult), physician-scientist, and educator. He has more than 200 publications and has had leadership positions in national and international organizations related to diabetes and endocrinology.
Education & Training
- Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1987
- Massachusetts General HospitalResidency, Internal Medicine, 1983 - 1986
- Duke University HospitalResidency, Internal Medicine, 1979 - 1982
- University of Tennessee Health Science Center College of MedicineClass of 1979
Certifications & Licensure
- TN State Medical License 1988 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2023
- President, Medicine and Society American Diabetes Association, 2017
- Board of Directors American Diabetes Association, 2014-2016
- Join now to see all
Clinical Trials
- Multicenter Assessment of the Pancreas in Type 1 Diabetes Start of enrollment: 2014 Feb 19
Publications & Presentations
PubMed
- Interruption of glucagon signaling augments islet non-alpha cell proliferation in SLC7A2- and mTOR-dependent manners.Katie C Coate, Chunhua Dai, Ajay Singh, Jade Stanley, Brittney A Covington
Molecular Metabolism. 2024-12-01 - Heterogeneous endocrine cell composition defines human islet functional phenotypes.Carmella Evans-Molina, Yasminye D Pettway, Diane C Saunders, Seth A Sharp, Thomas Sr Bate
Biorxiv. 2024-11-21 - Thermal Denaturation of Fresh Frozen Tissue Enhances Mass Spectrometry Detection of Peptides.Angela R S Kruse, Audra M Judd, Danielle B Gutierrez, Jamie L Allen, Martin Dufresne
Analytical Chemistry. 2024-10-22
Press Mentions
- Leading GLP-1 Expert Shares Insights on Groundbreaking Drugs for Glucose Control, Weight LossDecember 18th, 2024
- Diabetes Day Spotlights Achievements, Current InvestigationsJune 6th, 2024
- COVID-19 Can Infiltrate Insulin-Producing Cells in the Pancreas, Study SuggestsJune 1st, 2021
- Join now to see all
Professional Memberships
- Member
- Member
- International Society of EndocrinologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: